Investigating inflammation in a type of inherited blindness
Inflammation in MERTK-dependent retinitis pigmentosa
This study is looking at how inflammation affects retinitis pigmentosa, a genetic eye condition that can cause vision loss, by using mice to see how a missing gene called MERTK impacts the eye's ability to clean up debris, with the hope of finding new treatment options for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11017023 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of inflammation in retinitis pigmentosa, a genetic condition that can lead to blindness. The researchers are using mouse models to explore how the loss of a specific gene, MERTK, affects the ability of retinal cells to clear debris from photoreceptors. By examining the relationship between MERTK and inflammation in the retina, the study aims to uncover new insights into the disease process and potential therapeutic targets. Patients may benefit from findings that could lead to new treatments for retinitis pigmentosa.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with retinitis pigmentosa, particularly those with genetic mutations affecting the MERTK gene.
Not a fit: Patients with retinitis pigmentosa caused by other genetic mutations unrelated to MERTK may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies to prevent or slow down vision loss in patients with retinitis pigmentosa.
How similar studies have performed: Previous research has shown promising results in understanding the role of inflammation in retinal diseases, suggesting that this approach may yield valuable insights.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Rothlin, Carla — Yale University
- Study coordinator: Rothlin, Carla
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.